Phastar Achieves B Rating in CDP, Strengthening Our Leadership in Corporate Responsibility 

2 minute read

Published: March 24th, 2025

As we celebrate B Corp Month, Phastar reaffirms its commitment to responsible business practices that drive real impact. We continue to drive sustainability through initiatives such as our net-zero targets, pro bono biometrics support for charities, and ESG-driven clinical trial solutions. 

Additionally, we are proud to announce that Phastar has improved its CDP sustainability score, achieving a commendable B rating this year. This progress reflects our commitment to environmental transparency and action, recognizing the measurable steps we have taken to enhance emissions management, climate risk assessment, and sustainability initiatives. 

CDP is a global non-profit that runs the world’s only independent environmental disclosure system for companies to manage their environmental impacts. Achieving a B rating places Phastar in the Management band, highlighting our dedication to integrating climate considerations into our operations and decision-making. 

This recognition reinforces our mission to lead the CRO industry in responsible business practices that benefit our communities, employees, clients, and the environment. 

This B Corp Month, we celebrate the businesses proving that corporate responsibility isn’t just an ideal—it’s a necessity. We’re proud to be leading the charge in the CRO space, showing that scientific excellence and ethical leadership go hand in hand. 

Related articles

Meet the Team: Alice Spencer, Senior Statistician

Meet the Team: Alice Spencer, Senior Statistician

November 6th, 2025 3 minute read

In our “Meet the Team” series, we highlight the talented individuals who drive Phastar’s success. Each te...

The Need for a DMC and the Operational Role of an Independent Data Analysis Center: Practical Insights for Sponsors 

The Need for a DMC and the Operational Role of an Independent Data Analysis Center: Practical Insights for Sponsors 

November 4th, 2025 5 minute read

Introduction  Data Monitoring Committees (DMCs) play a pivotal role in protecting the rights, safety and well-being o...

The Rise of Innovative Trial Designs in Rare Disease Research 

The Rise of Innovative Trial Designs in Rare Disease Research 

October 28th, 2025 6 minute read

By Billy Amzal, Head of Strategic Consulting, Phastar  Introduction  Rare disease research demands tailored...